Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Alexopoulos

Showing results (231-240 of 387) with videos related to

Pageof 39
Sort By:
Cardiovascular Drugs and Therapy|July 8, 2015
Adenosine as an Adjunct Therapy in ST Elevation Myocardial Infarction Patients: Myth or Truth?George Kassimis, Periklis Davlouros, Niket Patel, et al.
Atherosclerosis|May 9, 2017
Noninvasive detection of increased carotid artery temperature in patients with coronary artery disease predicts major cardiovascular events at one year: Results from a prospective multicenter studyKonstantinos Toutouzas, Georgios Benetos, Iosif Koutagiar, et al.
British Journal of Clinical Pharmacology|July 2, 2016
Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patientsJolanta M Siller-Matula, Simon Specht, Jacek Kubica, et al.
Circulation. Cardiovascular Interventions|November 22, 2012
Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarctionDimitrios Alexopoulos, Ioanna Xanthopoulou, Vassilios Gkizas, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 21, 2016
Culprit plaque morphology in STEMI - an optical coherence tomography study: insights from the TOTAL-OCT substudyOlli A Kajander, Natalia Pinilla-Echeverri, Sanjit S Jolly, et al.
Journal of the American College of Cardiology|July 14, 2012
Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic studyDimitrios Alexopoulos, Anastasia Galati, Ioanna Xanthopoulou, et al.
Platelets|April 15, 2021
Not-high before-treatment platelet reactivity in patients with STEMI: prevalence, clinical characteristics, response to therapy and outcomesMario E Canonico, Giuseppe D Sanna, Roberta Siciliano, et al.
International Journal of Cardiology|May 17, 2016
A contemporary cross-sectional study on dyslipidemia management, cardiovascular risk status, and patients' quality of life in Greece: The CHALLENGE studyDimitrios Alexopoulos, Maria Anastasiou-Nana, Moses S Elisaf, et al.
Platelets|February 3, 2017
Dyspnea in patients treated with P2Y<sub>12</sub> receptor antagonists: insights from the GReek AntiPlatElet (GRAPE) registryDimitrios Alexopoulos, Ioanna Xanthopoulou, Angelos Perperis, et al.
JACC. Cardiovascular Interventions|May 22, 2010
Morphological characteristics of culprit atheromatic plaque are associated with coronary flow after thrombolytic therapy: new implications of optical coherence tomography from a multicenter studyKonstantinos Toutouzas, Elefterios Tsiamis, Antonios Karanasos, et al.
Pageof 39

Showing results (231-240 of 387) with videos related to

Sort By:
Pageof 39
Cardiovascular Drugs and Therapy|July 8, 2015
Adenosine as an Adjunct Therapy in ST Elevation Myocardial Infarction Patients: Myth or Truth?George Kassimis, Periklis Davlouros, Niket Patel, et al.
Atherosclerosis|May 9, 2017
Noninvasive detection of increased carotid artery temperature in patients with coronary artery disease predicts major cardiovascular events at one year: Results from a prospective multicenter studyKonstantinos Toutouzas, Georgios Benetos, Iosif Koutagiar, et al.
British Journal of Clinical Pharmacology|July 2, 2016
Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patientsJolanta M Siller-Matula, Simon Specht, Jacek Kubica, et al.
Circulation. Cardiovascular Interventions|November 22, 2012
Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarctionDimitrios Alexopoulos, Ioanna Xanthopoulou, Vassilios Gkizas, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 21, 2016
Culprit plaque morphology in STEMI - an optical coherence tomography study: insights from the TOTAL-OCT substudyOlli A Kajander, Natalia Pinilla-Echeverri, Sanjit S Jolly, et al.
Journal of the American College of Cardiology|July 14, 2012
Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic studyDimitrios Alexopoulos, Anastasia Galati, Ioanna Xanthopoulou, et al.
Platelets|April 15, 2021
Not-high before-treatment platelet reactivity in patients with STEMI: prevalence, clinical characteristics, response to therapy and outcomesMario E Canonico, Giuseppe D Sanna, Roberta Siciliano, et al.
International Journal of Cardiology|May 17, 2016
A contemporary cross-sectional study on dyslipidemia management, cardiovascular risk status, and patients' quality of life in Greece: The CHALLENGE studyDimitrios Alexopoulos, Maria Anastasiou-Nana, Moses S Elisaf, et al.
Platelets|February 3, 2017
Dyspnea in patients treated with P2Y<sub>12</sub> receptor antagonists: insights from the GReek AntiPlatElet (GRAPE) registryDimitrios Alexopoulos, Ioanna Xanthopoulou, Angelos Perperis, et al.
JACC. Cardiovascular Interventions|May 22, 2010
Morphological characteristics of culprit atheromatic plaque are associated with coronary flow after thrombolytic therapy: new implications of optical coherence tomography from a multicenter studyKonstantinos Toutouzas, Elefterios Tsiamis, Antonios Karanasos, et al.
Pageof 39